China Tracker - Safety/Risk Model (Stage One) for Biostar Pharmaceuticals (BSPM)

 Biostar Pharmaceuticals
 Going Public
Market Segment: NCM
Going Public: 2007-11-01Direct Offering 
 Auditor
Auditor: Mazars CPA
Number of Auditors (since Jan 1, 2009): 3
Auditor Resignations (since Jan 1, 2009): 1
 Internal Controls
Internal Controls (Management): effective
Internal Controls (Audit): not performed 
Senior Management Changes (since Jan 1, 2009): 2 
Number of CFOs (since Jan 1, 2009): 3
CFO Resignations (since Jan 1, 2009): 2
Main Shareholder (Ronghua Wang): Chairman, CEO 
Ownership Percentage: 33.28% 
 Analyst Coverage
Total Coverage: 2 Analyst(s) 
Tier 1 Firms: 0 Analyst(s) 
Tier 2/3 Firms: 1 Analyst(s) 
 Indicators
New Shares / Dilution (TTM): 0.14 million1.50%
Short Interest (2010-06-30): 0.05 million0.08% 
Account Receivables (MRQ): $23.58 million192.97%
 Recent Events
Delinquent with SEC Filings: NO 
Short Seller Attacks (Corporate Governance): NO 
Detailed Fraud Allegations: NO 
 
 Auditor History (since January 1, 2009)
2010-01-22Mazars CPAAppointment
2010-01-22Acquavella, Chiarelli, Shuster, Berkower & Co.Dismissal
2009-06-30Acquavella, Chiarelli, Shuster, Berkower & Co.Appointment
2009-06-30Morgenstern, Svoboda & BaerResignation
 Senior Management Trail (since January 1, 2009)
2011-04-07Zack Zibing PanCFOAppointment
2011-04-06Deyin ChenCFOResignation
2010-07-01Deyin ChenCFOAppointment
2010-06-30Elaine ZhaoCFOResignation
2007-07-01Elaine ZhaoCFOAppointment
BSPM
Healthcare & Drugs
SAFETY/RISK SCORE
30%
EXTREME RISK
Detailed Score: 260/850
Current Price:  $1.30
F10k Day (2009-08-14): -89.17%$12.00
2009 Close: -90.27%$13.35
2010 Close: -84.64%$8.46
High (2012-04-23): -38.39%$2.11
Low (2012-04-03): 132.14%$0.56
Exchange: NCM
Market Capitalization: 12.22 mill
Total Shares: 9.40 mill
Float: 2,220,000.00 mill
Last Quarter: 2012-06-30
Revenue (MRQ): 8.16 mill
Net Income (MRQ): -1.58 mill
Op. Cash Flow (MRQ): -3.02 mill
all financial data provided without warranty